Valuation CSPC Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. Other stock markets 09:08:12 03/08/2026 BST			5-day change	1st Jan Change
8.465 ^HKD	-1.34%		+1.99%	+0.42%

02:43am	CSPC Pharma Wins China Trial Approval for RSV Vaccine	MT
07-31	CSPC Pharmaceutical Group Limited Initiates Phase II Clinical Trial Of SYS6041 as Combination Therapy for Treatment of Recurrent Ovarian Cancer At First Centre in China	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	100,932	97,707	86,022	55,169	96,380	98,095	-	-
Change	-	-3.19%	-11.96%	-35.87%	74.7%	1.78%	-	-
Enterprise Value (EV) ¹	89,633	86,241	72,284	46,931	86,710	87,381	84,258	80,676
Change	-	-3.79%	-16.18%	-35.07%	84.76%	0.77%	-3.57%	-4.25%
P/E	14.7x	14.1x	13.5x	12.1x	21.8x	11.9x	13.9x	12.8x
PBR	3.17x	2.86x	2.39x	1.62x	2.56x	2.28x	2.08x	1.9x
PEG	-	14.13x	-1.73x	-0.5x	-9.88x	0.1x	-1x	1.45x
Capitalization / Revenue	2.94x	2.77x	2.52x	1.78x	3.26x	2.75x	2.79x	2.61x
EV / Revenue	2.61x	2.44x	2.12x	1.51x	2.94x	2.45x	2.4x	2.15x
EV / EBITDA	9.5x	9.43x	8.39x	6.22x	12.1x	6.84x	8.49x	7.66x
EV / EBIT	10.7x	10.8x	9.77x	7.68x	15.6x	9.47x	10.9x	9.85x
EV / FCF	23.7x	14.1x	26.2x	17.5x	19.5x	11.9x	12.1x	8.61x
FCF Yield	4.22%	7.11%	3.82%	5.71%	5.12%	8.43%	8.28%	11.6%
Dividend per Share ²	0.18	0.21	0.28	0.26	0.29	0.3699	0.3697	0.3847
Rate of return	2.13%	2.56%	3.86%	5.44%	3.44%	4.31%	4.31%	4.48%
EPS ²	0.5773	0.5831	0.5376	0.3946	0.3859	0.7189	0.6181	0.6728
Distribution rate	31.2%	36%	52.1%	65.9%	75.2%	51.5%	59.8%	57.2%
Net sales ¹	34,309	35,292	34,175	31,046	29,533	35,696	35,175	37,540
EBITDA ¹	9,431	9,148	8,615	7,547	7,168	12,782	9,929	10,529
EBIT ¹	8,366	7,952	7,400	6,113	5,564	9,230	7,705	8,187
Net income ¹	6,901	6,949	6,382	4,632	4,409	7,935	6,932	7,548
Net Debt ¹	-11,298	-11,467	-13,738	-8,238	-9,670	-10,715	-13,838	-17,420
Reference price ²	8.470	8.200	7.260	4.780	8.430	8.580	8.580	8.580
Nbr of stocks (in thousands)	11,916,370	11,915,520	11,848,756	11,541,665	11,433,025	11,433,025	-	-
Announcement Date	22/03/22	22/03/23	20/03/24	28/03/25	25/03/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CSPC PHARMACEUTICAL GROUP LIMITED	11.93x	2.45x	6.84x	4.31%	12.51B
ELI LILLY AND COMPANY	35.03x	12.19x	25.61x	0.59%	1,024B
JOHNSON & JOHNSON	27.48x	6.29x	17.54x	2.1%	618B
ABBVIE INC.	32.57x	7.42x	15.36x	2.76%	443B
ROCHE HOLDING AG	19.7x	4.68x	11.59x	2.83%	349B
NOVARTIS AG	22.21x	5.74x	14.32x	2.8%	297B
ASTRAZENECA PLC	21.76x	4.48x	12.7x	1.96%	264B
NOVO NORDISK A/S	13.48x	5.05x	10.4x	3.71%	209B
AMGEN INC.	25.29x	6.61x	11.66x	2.62%	208B
GILEAD SCIENCES, INC.	-46.92x	5.63x	31.08x	2.53%	162B
Average	16.25x	6.05x	15.71x	2.62%	358.63B
Weighted average by Cap.	24.30x	7.68x	18.19x	2.02%